DK0771201T3 - Anvendelse af 2-phenyl-3-aroylbenzothiophener til fremstilling af et medikament til inhibering af primær endometrisk hyperplasi - Google Patents

Anvendelse af 2-phenyl-3-aroylbenzothiophener til fremstilling af et medikament til inhibering af primær endometrisk hyperplasi

Info

Publication number
DK0771201T3
DK0771201T3 DK95930875T DK95930875T DK0771201T3 DK 0771201 T3 DK0771201 T3 DK 0771201T3 DK 95930875 T DK95930875 T DK 95930875T DK 95930875 T DK95930875 T DK 95930875T DK 0771201 T3 DK0771201 T3 DK 0771201T3
Authority
DK
Denmark
Prior art keywords
phenyl
aroylbenzothiophenes
drug
prepare
endometrial hyperplasia
Prior art date
Application number
DK95930875T
Other languages
Danish (da)
English (en)
Inventor
Robin Sharon Lee Fuchs-Young
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0771201T3 publication Critical patent/DK0771201T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
DK95930875T 1994-08-22 1995-08-21 Anvendelse af 2-phenyl-3-aroylbenzothiophener til fremstilling af et medikament til inhibering af primær endometrisk hyperplasi DK0771201T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29412194A 1994-08-22 1994-08-22
PCT/US1995/010619 WO1996005832A1 (en) 1994-08-22 1995-08-21 Methods of inhibiting primary endometrial hyperplasia

Publications (1)

Publication Number Publication Date
DK0771201T3 true DK0771201T3 (da) 2001-05-07

Family

ID=23131973

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95930875T DK0771201T3 (da) 1994-08-22 1995-08-21 Anvendelse af 2-phenyl-3-aroylbenzothiophener til fremstilling af et medikament til inhibering af primær endometrisk hyperplasi

Country Status (20)

Country Link
EP (1) EP0771201B1 (cs)
JP (1) JPH10504579A (cs)
KR (1) KR970705388A (cs)
AT (1) ATE200623T1 (cs)
AU (1) AU706953B2 (cs)
CA (1) CA2198120A1 (cs)
CZ (1) CZ52297A3 (cs)
DE (1) DE69520741T2 (cs)
DK (1) DK0771201T3 (cs)
ES (1) ES2155895T3 (cs)
FI (1) FI970716A7 (cs)
GR (1) GR3036225T3 (cs)
HU (1) HUT76854A (cs)
IL (1) IL115018A0 (cs)
MX (1) MX9701359A (cs)
MY (1) MY131931A (cs)
NO (1) NO970787D0 (cs)
PT (1) PT771201E (cs)
WO (1) WO1996005832A1 (cs)
ZA (1) ZA956988B (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW404834B (en) * 1994-08-22 2000-09-11 Lilly Co Eli Pharmaceutical compositions for inhibiting endometrial cancer
US5843964A (en) * 1994-09-22 1998-12-01 Eli Lilly And Company Methods of inhibiting endometrial mitoses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
ZA948025B (en) * 1993-10-15 1996-04-15 Lilly Co Eli Methods for treating resistant neoplasms
US5461065A (en) * 1993-10-15 1995-10-24 Eli Lilly And Company Methods for inhibiting endometriosis

Also Published As

Publication number Publication date
EP0771201A4 (en) 1997-09-10
EP0771201A1 (en) 1997-05-07
MX9701359A (es) 1997-05-31
WO1996005832A1 (en) 1996-02-29
CZ52297A3 (en) 1997-08-13
CA2198120A1 (en) 1996-02-29
FI970716L (fi) 1997-02-20
NO970787L (no) 1997-02-20
FI970716A0 (fi) 1997-02-20
KR970705388A (ko) 1997-10-09
ATE200623T1 (de) 2001-05-15
ZA956988B (en) 1997-02-21
GR3036225T3 (en) 2001-10-31
AU3409895A (en) 1996-03-14
DE69520741T2 (de) 2001-10-11
HUT76854A (en) 1997-12-29
JPH10504579A (ja) 1998-05-06
PT771201E (pt) 2001-07-31
EP0771201B1 (en) 2001-04-18
AU706953B2 (en) 1999-07-01
NO970787D0 (no) 1997-02-20
DE69520741D1 (de) 2001-05-23
MY131931A (en) 2007-09-28
FI970716A7 (fi) 1997-02-20
IL115018A0 (en) 1995-12-08
ES2155895T3 (es) 2001-06-01

Similar Documents

Publication Publication Date Title
DK0652005T3 (da) Fremgangsmåder til inhibering af endometriose
MX9701329A (es) Metodos para la inhibicion de la replicacion viral.
DK0651999T3 (da) Fremgangsmåder til inhibering af livmoderfibrose
MX9701325A (es) Metodos para inhibir la mucositis ulcerativa.
MX9701360A (es) Metodos para la inhibicion de la desmielinizacion y las enfermedades de la dismielinizacion.
DK0659417T3 (da) Fremgangsmåder til inhibering af dysfunktionel blødning fra livmoderen
DK0659411T3 (da) Fremgangsmåde til forøgelse af libido hos kvinder efter menopausen
DK0652002T3 (da) Anvendelse af 2-phenyl-3-aroylebenzothiophener til fremstilling af et medikament til hæmning af brusknedbrydning
NO970786L (no) Fremgangsmåte for hemming av benprotesedegradering
MX9709466A (es) Medicamento para inhibir el melanoma.
EA199700136A1 (ru) Способы ингибирования экзогенных эстрогенов
MX9701333A (es) Metodos para inhibir el daño neuronal.
DK0771201T3 (da) Anvendelse af 2-phenyl-3-aroylbenzothiophener til fremstilling af et medikament til inhibering af primær endometrisk hyperplasi
MY113757A (en) Methods of inhibiting endometrial cancer
PH31620A (en) Benzothiophenes for bone healing and fracture repair.
MX9701328A (es) Metodos de reduccion de la cicatrizacion en la curacion de heridas.
MX9705697A (es) Metodos para reducir los niveles de calcio del suero.
MX9709536A (es) Metodo para reducir el factor de transcripcion bef-1.
MX9706072A (es) Metodos de inhibicion de la adhesion celula-celula.
MX9709651A (es) Metodos para modulacion del factor de transcripcion nf-kb.